Collaborative Practice Agreement Recertificate Program for License Renewal

This self-paced, fully online program is intended for pharmacists wishing to maintain the Collaborative Practice Agreement (CPA) certification in accordance with Florida law.

decor

Program Details

  • Intended Audience: Pharmacists wishing to maintain their collaborative practice agreement certification.
  • Universal Activity Number: 0012-0000-22-026-H99-P
  • Contact Hours: 8.0 hours of ACPE approved continuing education for pharmacists
  • Program Fees: 
    • Regular Registration: $110.00
    • UF Preceptor/Career Coach: $90.00
    • UF COP Faculty: $80.00
  • UAN Release Date: 07/11/2022
  • UAN Expiration Date: 07/11/2025
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.
  • Format Type: This course is self-paced, fully online.
  • Time to Complete: All coursework must be completed within 365 days from the date of registration or before date of UAN expiration, 07/11/2025, whichever comes first. This course will no longer be eligible for CE credit after 07/11/2025.

Summary

This certificate training program focuses on topics related to collaborative practice agreements between pharmacists and physicians. This program will expand upon content included in the Initial Collaborative Practice Agreement Certification program. Topics include but are not limited to:

  • Billing structures
  • Pharmacy quality improvement
  • Motivational interviewing
  • Legal and regulatory requirements associated with entering into a collaborative practice agreement
  • Patient assessment and treatments for chronic diseases outlined in Florida law

Objectives

At the completion of this activity, the participant will be able to:

  • Summarize the patient assessment process, drug therapy management, and associated pharmacotherapy guideline updates for the chronic disease states covered in the Collaborative Practice Agreement legislation.
  • Identify resources available to pharmacists to develop evidence-based treatment plans and improve quality metrics for the chronic disease states covered in the Collaborative Practice Agreement legislation.
  • Discuss common billing and documentation strategies for pharmacists who are working to effectively establish Collaborative Practice Agreement clinical services.
  • Employ motivational interviewing and other patient communication techniques in order to help patients achieve their health-related goals.
  • Describe the impact of pharmacy quality performance measurements on advancing Collaborative Practice Agreement clinical services.

Disease States Pharmacists Can Manage in a Collaborative Practice Agreements under Florida Board of Pharmacy Rules and Regulations:

Hypertension

Hyperlipidemia

COPD

Nicotine Dependence

Anticoagulation

Type 2 Diabetes

Hiv/AIds

Arthritis

Obesity

Asthma

Opiod-Use Disorder

blood glucose monitoring

A pharmacist who practices under a collaborative pharmacy practice agreement must complete an 8-hour continuing education course approved by the board that addresses issues related to collaborative pharmacy practice each biennial licensure renewal in addition to the continuing education requirements under s. 465.009. A pharmacist must submit confirmation of having completed such course when applying for licensure renewal. A pharmacist who fails to comply with this subsection shall be prohibited from practicing under a collaborative pharmacy practice agreement under this section.

This program meets the requirements outlined in Section 465.1865, Florida Statutes for pharmacists who wish to enter into a collaborative practice agreement with a supervising physician in the State of Florida. Visit the Florida Board of Pharmacy website to learn more about pharmacist requirements to enter into a Collaborative Practice Agreement.


Program Overview

Module 1: Collaborative Practice Agreement Disease State Pharmacotherapy Updates

Module 2: Establishing Collaborative Practice Agreement Clinical Services

Module 3: Motivational Interviewing

Module 4: Advancing Collaborative Practice Agreement Clinical Services


Disclosure Statement

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB (speaker) has disclosed that he receives an unrestricted Investigator-initiated Research Grant from BMS/Pfizer. All of the relevant financial relationships listed for Dr. Dietrich have been mitigated. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.

Rachel Shaddock

Rachel Shaddock

Resident
Eric A Dietrich

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Associate Professor
Bradley W Van Riper

Bradley W Van Riper Pharm.D.

POST DOC ASO
Teresa E Roane

Teresa E Roane PharmD, MBA, BCACP

Director Continuing Pharmacy Education; Clinical Associate Professor
Eric F Egelund

Eric F Egelund Ph.D., Pharm.D.

Clinical Associate Professor

Requirements for Successful Course Completion

In order to earn credit for this course, participants must complete all course case study quizzes and pass a final assessment with a score of 70% or higher. Two chances to pass each quiz/assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.


Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.